© 2003 by Oxford University Press
© 2003 Oxford University Press
|
|
SPECIAL ARTICLE |
Annual Report to the Nation on the Status of Cancer, 1975–2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control
Affiliations of authors: H. K. Weir, P. A. Wingo, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA; M. J. Thun, A. Jemal, E. Ward, Epidemiology and Surveillance Research Department, American Cancer Society, Atlanta; B. F. Hankey, L. A. G. Ries, B. K. Edwards, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD; H. L. Howe, North American Association of Central Cancer Registries, Springfield, IL; R. N. Anderson, Division of Vital Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
Correspondence to: Hannah K. Weir, PhD, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, MS K-53, 4770 Buford Hwy., Atlanta, GA 30341 (e-mail: hbw4{at}cdc.gov).
Background: The American Cancer Society, the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to update cancer rates and trends in the United States. This report updates statistics on lung, female breast, prostate, and colorectal cancers and highlights the uses of selected surveillance data to assist development of state-based cancer control plans. Methods: Age-adjusted incidence rates from 1996 through 2000 are from state and metropolitan area cancer registries that met NAACCR criteria for highest quality. Death rates are based on underlying cause-of-death data. Long-term trends and rates for major racial and ethnic populations are based on NCI and CDC data. Incidence trends from 1975 through 2000 were adjusted for reporting delays. State-specific screening and risk factor survey data are from the CDC and other federal and private organizations. Results: Cancer incidence rates for all cancer sites combined increased from the mid-1970s through 1992 and then decreased from 1992 through 1995. Observed incidence rates for all cancers combined were essentially stable from 1995 through 2000, whereas the delay-adjusted trend showed an increase that had borderline statistical significance (P = .05). Increases in the incidence rates of breast cancer in women and prostate cancer in men offset a long-term decrease in lung cancer in men. Death rates for all cancer sites combined decreased beginning in 1994 and stabilized from 1998 through 2000, resulting in part from recent revisions in cause-of-death codes. Death rates among men continued to decline throughout the 1990s, whereas trends in death rates among women were essentially unchanged from 1998 through 2000. Analysis of state data for the leading cancers revealed mixed progress in achieving national objectives for improving cancer screening, risk factor reduction, and decreases in mortality. Conclusions: Overall cancer incidence and death rates began to stabilize in the mid- to late 1990s. The recent increase in the delay-adjusted trend will require monitoring with additional years of data. Further reduction in the burden of cancer is possible but will require the continuation of strong federal, state, local, and private partnerships to increase dissemination of evidence-based cancer control programs to all segments of the population.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., March 28, 2008; (2008) dyn055v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hoffman, N. D. Shah, L. C. Vermeulen, F. Doloresco, P. Grim, R. J. Hunkler, K. M. Hontz, and G. T. Schumock Projecting future drug expenditures--2008 Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 234 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Connolly, A. Black, A. Gavin, P. F. Keane, and L. J. Murray Baseline Prostate-Specific Antigen Level and Risk of Prostate Cancer and Prostate-Specific Mortality: Diagnosis Is Dependent on the Intensity of Investigation Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Asmis, K. Ding, L. Seymour, F. A. Shepherd, N. B. Leighl, T. L. Winton, M. Whitehead, J. N. Spaans, B. C. Graham, and G. D. Goss Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non-Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials J. Clin. Oncol., January 1, 2008; 26(1): 54 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J A. Lane, J. Howson, J. L Donovan, J. R Goepel, D. J Dedman, L. Down, E. L Turner, D. E Neal, and F. C Hamdy Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial BMJ, December 1, 2007; 335(7630): 1139 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wu, M. S. O'Reilly, R. R. Langley, R. Z. Tsan, C. H. Baker, N. Bekele, X. M. Tang, A. Onn, I. J. Fidler, and R. S. Herbst Expression of epidermal growth factor (EGF)/transforming growth factor-{alpha} by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice Mol. Cancer Ther., October 1, 2007; 6(10): 2652 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. B. Benard, S. S. Coughlin, T. Thompson, and L. C. Richardson Cervical Cancer Incidence in the United States by Area of Residence, 1998 2001 Obstet. Gynecol., September 1, 2007; 110(3): 681 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. HOISINGTON, D. L. SCHERER, and K. L. BERGER Breast MR Imaging: Applications and Pitfalls Radiol. Technol., May 1, 2007; 78(5): 367 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U.S. Preventive Services Task Force* Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med, March 6, 2007; 146(5): 361 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Been, A. J.H. Suurmeijer, P. H. Elsinga, P. L. Jager, R. J. van Ginkel, and H. J. Hoekstra 18F-Fluorodeoxythymidine PET for Evaluating the Response to Hyperthermic Isolated Limb Perfusion for Locally Advanced Soft-Tissue Sarcomas J. Nucl. Med., March 1, 2007; 48(3): 367 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sanchez, P. Alama, B. Gadea, S.R. Soares, C. Simon, and A. Pellicer Fresh human orthotopic ovarian cortex transplantation: long-term results Hum. Reprod., March 1, 2007; 22(3): 786 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hoffman, N. D. Shah, L. C. Vermeulen, G. T. Schumock, P. Grim, R. J. Hunkler, and K. M. Hontz Projecting future drug expenditures--2007 Am. J. Health Syst. Pharm., February 1, 2007; 64(3): 298 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Goldstein, O. Gofrit, A. Nyska, and S. Benita Anti-HER2 Cationic Immunoemulsion as a Potential Targeted Drug Delivery System for the Treatment of Prostate Cancer Cancer Res., January 1, 2007; 67(1): 269 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Losina, R. P. Walensky, A. Geller, F. C. Beddingfield III, L. L. Wolf, B. A. Gilchrest, and K. A. Freedberg Visual Screening for Malignant Melanoma: A Cost-effectiveness Analysis Arch Dermatol, January 1, 2007; 143(1): 21 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Robinson, R. Turrisi, and J. Stapleton Efficacy of a Partner Assistance Intervention Designed to Increase Skin Self-examination Performance Arch Dermatol, January 1, 2007; 143(1): 37 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Gozgit, B. T. Pentecost, S. A. Marconi, C. N. Otis, C. Wu, and K. F. Arcaro Use of an Aggressive MCF-7 Cell Line Variant, TMX2-28, to Study Cell Invasion in Breast Cancer Mol. Cancer Res., December 1, 2006; 4(12): 905 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Lewis, R. M. Harbord, R. Harris, and G. D. Smith Meta-analyses of Observational and Genetic Association Studies of Folate Intakes or Levels and Breast Cancer Risk. J Natl Cancer Inst, November 15, 2006; 98(22): 1607 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Peng, X. Lu, J. Janisse, O. Muzik, and A. F. Shields PET of Human Prostate Cancer Xenografts in Mice with Increased Uptake of 64CuCl2 J. Nucl. Med., October 1, 2006; 47(10): 1649 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Henning, W. Aronson, Y. Niu, F. Conde, N. H. Lee, N. P. Seeram, R.-P. Lee, J. Lu, D. M. Harris, A. Moro, et al. Tea Polyphenols and Theaflavins Are Present in Prostate Tissue of Humans and Mice after Green and Black Tea Consumption J. Nutr., July 1, 2006; 136(7): 1839 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. McGlynn, R. E. Tarone, and H. B. El-Serag A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1198 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Simon, J. F. Korczak, C. L. Yee, K. E. Malone, G. Ursin, L. Bernstein, J. A. McDonald, D. Deapen, B. L. Strom, M. F. Press, et al. Breast Cancer Risk Estimates for Relatives of White and African American Women With Breast Cancer in the Women's Contraceptive and Reproductive Experiences Study J. Clin. Oncol., June 1, 2006; 24(16): 2498 - 2504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Neugut, M. Matasar, X. Wang, R. McBride, J. S. Jacobson, W.-Y. Tsai, V. R. Grann, and D. L. Hershman Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly J. Clin. Oncol., May 20, 2006; 24(15): 2368 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Paulus, E. R. Stanley, R. Schafer, D. Abraham, and S. Aharinejad Colony-stimulating factor-1 antibody reverses chemoresistance in human mcf-7 breast cancer xenografts. Cancer Res., April 15, 2006; 66(8): 4349 - 4356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Trock, L. Hilakivi-Clarke, and R. Clarke Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst, April 5, 2006; 98(7): 459 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Hillier, J. C. Marquis, B. Zayas, J. S. Wishnok, R. G. Liberman, P. L. Skipper, S. R. Tannenbaum, J. M. Essigmann, and R. G. Croy DNA adducts formed by a novel antitumor agent 11{beta}-dichloro in vitro and in vivo. Mol. Cancer Ther., April 1, 2006; 5(4): 977 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Guo, P. A. Marcotte, J. O. McCall, Y. Dai, L. J. Pease, M. R. Michaelides, S. K. Davidsen, and K. B. Glaser Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors. Mol. Cancer Ther., April 1, 2006; 5(4): 1007 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Bickell, J. J. Wang, S. Oluwole, D. Schrag, H. Godfrey, K. Hiotis, J. Mendez, and A. A. Guth Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment J. Clin. Oncol., March 20, 2006; 24(9): 1357 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hoffman, N. D. Shah, L. C. Vermeulen, G. T. Schumock, P. Grim, R. J. Hunkler, and K. M. Hontz Projecting future drug expenditures--2006 Am. J. Health Syst. Pharm., January 15, 2006; 63(2): 123 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Huff, W. Matsui, B. D. Smith, and R. J. Jones The paradox of response and survival in cancer therapeutics Blood, January 15, 2006; 107(2): 431 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al. Epidemiology and costs of chronic obstructive pulmonary disease Eur. Respir. J., January 1, 2006; 27(1): 188 - 207. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Feller-Kopman, W. Lunn, and A. Ernst Autofluorescence Bronchoscopy and Endobronchial Ultrasound: A Practical Review Ann. Thorac. Surg., December 1, 2005; 80(6): 2395 - 2401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Heitman, B. J. Manns, R. J. Hilsden, A. Fong, S. Dean, and J. Romagnuolo Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening Can. Med. Assoc. J., October 11, 2005; 173(8): 877 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Edwards, M. L. Brown, P. A. Wingo, H. L. Howe, E. Ward, L. A. G. Ries, D. Schrag, P. M. Jamison, A. Jemal, X. C. Wu, et al. Annual Report to the Nation on the Status of Cancer, 1975-2002, Featuring Population-Based Trends in Cancer Treatment J Natl Cancer Inst, October 5, 2005; 97(19): 1407 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Clements, B. K. Armstrong, and S. H. Moolgavkar Lung cancer rate predictions using generalized additive models Biostat., October 1, 2005; 6(4): 576 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Ferguson, M. R. Muenster, Q. Zang, J. A. Spencer, J. J. Schageman, Y. Lian, H. R. Garner, R. B. Gaynor, J. W. Huff, A. Pertsemlidis, et al. Selective Identification of Secreted and Transmembrane Breast Cancer Markers using Escherichia coli Ampicillin Secretion Trap Cancer Res., September 15, 2005; 65(18): 8209 - 8217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Sansbury, R. C. Millikan, J. C. Schroeder, P. G. Moorman, K. E. North, and R. S. Sandler Use of Nonsteroidal Antiinflammatory Drugs and Risk of Colon Cancer in a Population-based, Case-Control Study of African Americans and Whites Am. J. Epidemiol., September 15, 2005; 162(6): 548 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Meisamy, P. J. Bolan, E. H. Baker, M. G. Pollema, C. T. Le, F. Kelcz, M. C. Lechner, B. A. Luikens, R. A. Carlson, K. R. Brandt, et al. Adding in Vivo Quantitative 1H MR Spectroscopy to Improve Diagnostic Accuracy of Breast MR Imaging: Preliminary Results of Observer Performance Study at 4.0 T Radiology, August 1, 2005; 236(2): 465 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Thompson, D. P. Ankerst, C. Chi, M. S. Lucia, P. J. Goodman, J. J. Crowley, H. L. Parnes, and C. A. Coltman Jr Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower JAMA, July 6, 2005; 294(1): 66 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-S. Zhu, L.-Q. Cai, Y. Huang, J. Fish, L. Wang, Z.-K. Zhang, and J. L. Imperato-McGinley Receptor Isoform and Ligand-Specific Modulation of Dihydrotestosterone-Induced Prostate Specific Antigen Gene Expression and Prostate Tumor Cell Growth by Estrogens J Androl, July 1, 2005; 26(4): 500 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sato, M. Johnson, L. Zhang, S. S. Gambhir, M. Carey, and L. Wu Functionality of Androgen Receptor-Based Gene Expression Imaging in Hormone Refractory Prostate Cancer Clin. Cancer Res., May 15, 2005; 11(10): 3743 - 3749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Nichols, A. Trentham-Dietz, J. M. Hampton, and P. A. Newcomb Oral Contraceptive Use, Reproductive Factors, and Colorectal Cancer Risk: Findings from Wisconsin Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1212 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Chlebowski, Z. Chen, G. L. Anderson, T. Rohan, A. Aragaki, D. Lane, N. C. Dolan, E. D. Paskett, A. McTiernan, F. A. Hubbell, et al. Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome J Natl Cancer Inst, March 16, 2005; 97(6): 439 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Elmore, K. Armstrong, C. D. Lehman, and S. W. Fletcher Screening for Breast Cancer JAMA, March 9, 2005; 293(10): 1245 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jemal, E. Ward, X. Wu, H. J. Martin, C. C. McLaughlin, and M. J. Thun Geographic Patterns of Prostate Cancer Mortality and Variations in Access to Medical Care in the United States Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 590 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bosetti, M. Malvezzi, L. Chatenoud, E. Negri, F. Levi, and C. La Vecchia Trends in cancer mortality in the Americas, 1970-2000 Ann. Onc., March 1, 2005; 16(3): 489 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Schimanski, S. Schwald, N. Simiantonaki, C. Jayasinghe, U. Gonner, V. Wilsberg, T. Junginger, M. R. Berger, P. R. Galle, and M. Moehler Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1743 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Liu, S. Varghese, and S. D. Rabkin Oncolytic Herpes Simplex Virus Vector Therapy of Breast Cancer in C3(1)/SV40 T-antigen Transgenic Mice Cancer Res., February 15, 2005; 65(4): 1532 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Arredondo, A. I. Chernyavsky, L. M. Marubio, A. L. Beaudet, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando Receptor-Mediated Tobacco Toxicity: Regulation of Gene Expression through {alpha}3{beta}2 Nicotinic Receptor in Oral Epithelial Cells Am. J. Pathol., February 1, 2005; 166(2): 597 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hoffman, N. D. Shah, L. C. Vermeulen, R. J. Hunkler, and K. M. Hontz Projecting future drug expenditures--2005 Am. J. Health Syst. Pharm., January 15, 2005; 62(2): 149 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T G Chang, M. Jhamai, W. M van Weerden, G. Jenster, and A. O Brinkmann The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 815 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Shaw, R. Etzioni, S. B. Zeliadt, A. Mariotto, K. Karnofski, D. F. Penson, N. S. Weiss, and E. J. Feuer An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States Am. J. Epidemiol., December 1, 2004; 160(11): 1059 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Greenwald Clinical Trials in Cancer Prevention: Current Results and Perspectives for the Future J. Nutr., December 1, 2004; 134(12): 3507S - 3512S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Alexander, A. L. Stegner, C. Wagner-Mann, G. C. Du Bois, S. Alexander, and E. R. Sauter Proteomic Analysis to Identify Breast Cancer Biomarkers in Nipple Aspirate Fluid Clin. Cancer Res., November 15, 2004; 10(22): 7500 - 7510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Petty, K. H. Dragnev, V. A. Memoli, Y. Ma, N. B. Desai, A. Biddle, T. H. Davis, W. C. Nugent, N. Memoli, M. Hamilton, et al. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers Clin. Cancer Res., November 15, 2004; 10(22): 7547 - 7554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Roberts Jr, B. H. Goulart, L. Squitieri, S. C. Stallings, E. F. Halpern, B. A. Chabner, G. S. Gazelle, S. N. Finkelstein, and J. W. Clark Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials JAMA, November 3, 2004; 292(17): 2130 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. McDonald, D. Saslow, and M. H. Al |